Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Plos One|August 17, 2013
Identification and validation of a multigene predictor of recurrence in primary laryngeal cancerElena Fountzilas, Vassiliki Kotoula, Nikolaos Angouridakis, et al.
Clinical Breast Cancer|May 26, 2010
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology GroupHelen Gogas, Dimitrios Pectasides, Ioannis Kostopoulos, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictorsGeorge Pentheroudakis, George Fountzilas, Haralabos P Kalofonos, et al.
Anticancer Research|January 4, 2012
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2Paris A Kosmidis, Konstantinos Syrigos, Haralampos P Kalofonos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology GroupParis A Kosmidis, Meletios-Athanasios Dimopoulos, Konstantinos Syrigos, et al.
Gynecologic Oncology|September 24, 2004
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II studyDimitrios Pectasides, Melina Pectasides, Dimitrios Farmakis, et al.
Anticancer Research|April 1, 2009
Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experienceDimitrios Pectasides, Eirini Pectasides, George Papaxoinis, et al.
Anticancer Research|February 5, 2020
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II StudyJoseph Sgouros, Gerasimos Aravantinos, Georgia-Angeliki Koliou, et al.
Anticancer Research|July 28, 2004
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group studyHelen Gogas, Dimitrios Bafaloukos, John Ioannovich, et al.
Anticancer Research|January 12, 2007
Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluationGeorge Fountzilas, George Karkavelas, Anna Kalogera-Fountzila, et al.
Pageof 19